IP Library Granted Patent US 11,896,024
Granted Patent B2
US 11,896,024 · App. 17/687,786 · Granted Feb 13, 2024

Method of glycation of a polypeptide

Inventor: Jeppe Wegener Tams (Gentofte, DK)
Assignee: Novozymes A/S
A23C9/1206A23C9/1307A23C9/1512C12P19/04C12P19/18C12Y302/01023C12Y302/01108
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,896,024
App. No.
17/687,786
Granted
Feb 13, 2024
Kind
B2
Abstract

The present invention relates to compositions, particularly liquid compositions, comprising enzymes, methods of making the compositions, and uses of the same for making, e.g., dairy products.

Claims (14)

1. A method of modifying by glycation a polypeptide having beta-galactosidase activity, comprising:

contacting the polypeptide with 30-90 wt % of a reducing sugar under conditions sufficient to produce a polypeptide modified by glycation,

wherein the reducing sugar is fructose, galactose, glucose, glyceraldehyde, ribose, xylose, cellobiose, maltose, or lactose, wherein the conditions comprise contacting the polypeptide in a solution at pH 5-8, for a time of 3-100 hours, at a temperature of 50-80° C., and wherein the polypeptide has at least 3% of lysine and arginine residues of the polypeptide modified by glycation.

2. The method of claim 1 , wherein the polypeptide has improved transgalactosylating activity as compared to a polypeptide having beta-galactosidase activity which has not been modified by glycation.

3. The method of claim 1 , wherein the polypeptide has at least 5% of lysine and arginine residues of the polypeptide modified by glycation.

4. The method of claim 1 , wherein the polypeptide is contacted with 40-65 wt. % of a reducing sugar.

5. The method of claim 1 , wherein the polypeptide is from subfamily 5 of glycosyl hydrolase family 2 (GH2_5).

6. The method of claim 1 , wherein the polypeptide is from subfamily 6 of glycosyl hydrolase family 2 (GH2_6).

7. The method of claim 1 , wherein the polypeptide is a Bacillus polypeptide.

8. The method of claim 1 , wherein the polypeptide is a Bacillus circulans polypeptide.

9. The method of claim 1 , wherein the polypeptide is a Bifidobacterium polypeptide.

10. The method of claim 1 , wherein the polypeptide is a Bifidobacterium bifidum polypeptide.

11. The method of claim 1 , wherein the polypeptide is a Kluyvermyces polypeptide.

12. The method of claim 1 , wherein the polypeptide is a Kluyvermyces lactis polypeptide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2024
From: TAMS, JEPPE WEGENER
To: NOVOZYMES A/S
Reel/Frame 067553/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2024
From: NOVOZYMES A/S
To: KERRY GROUP SERVICES INTERNATIONAL LTD
Reel/Frame 067480/0489 →
Priority Claims (2)
EP 17171174 · May 15, 2017 · regional
EP 18162193 · Mar 16, 2018 · regional
Continuity (2)
Division 16609276
Related Publication 20220232843A1 · Jul 28, 2022